Key clinical point: Children who have recurrence of primary sclerosing cholangitis after liver transplant tend to be younger and have more rapidly progressive disease.
Major finding: Recurrence was significantly associated with younger median age at time of transplant (13.2 vs. 16.2 years).
Study details: A retrospective study involving 149 children who underwent liver transplant for primary sclerosing cholangitis.
Disclosures: The investigators disclosed relationships with Gilead, Merck, Novartis, and others.
Martinez M et al. The Liver Meeting 2019, Abstract 44.